This ubiquitination of MVP in the remodeled pulmonary vasculature with thickened PA smooth muscle was observed in two different rat models of PAH, namely SU5416 injection plus hypoxia and SU5416 injection plus ovalbumin immunization without changing the expression levels of MVP[17]. Here, MVP is linked to pulmonary arterial hypertension.